BioCentury
ARTICLE | Clinical News

Benlysta belimumab: Phase III started

April 8, 2013 7:00 AM UTC

GlaxoSmithKline began a double-blind, placebo-controlled Phase III trial to evaluate 10 mg/kg IV Benlysta plus 2 mg/kg oral azathioprine daily in about 400 patients with Wegener's granulomatosis or m...